0001162044-24-000508.txt : 20240520 0001162044-24-000508.hdr.sgml : 20240520 20240520120932 ACCESSION NUMBER: 0001162044-24-000508 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240328 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 PERIOD START: 20240630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DSS AMERICAFIRST QUANTITATIVE FUNDS CENTRAL INDEX KEY: 0001539996 ORGANIZATION NAME: IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-22669 FILM NUMBER: 24963070 BUSINESS ADDRESS: STREET 1: 9700 VILLAGE CENTER DRIVE STREET 2: SUITE 50-N CITY: GRANITE BAY STATE: CA ZIP: 95746 BUSINESS PHONE: 916-757-6862 MAIL ADDRESS: STREET 1: 9700 VILLAGE CENTER DRIVE STREET 2: SUITE 50-N CITY: GRANITE BAY STATE: CA ZIP: 95746 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAFIRST QUANTITATIVE FUNDS DATE OF NAME CHANGE: 20120119 0001539996 S000036986 DSS AmericaFirst Defensive Growth Fund C000113162 DSS AmericaFirst Defensive Growth Fund Class A DGQAX C000113163 DSS AmericaFirst Defensive Growth Fund Class U DGQUX C000113164 DSS AmericaFirst Defensive Growth Fund Class I DGQIX NPORT-P 1 primary_doc.xml NPORT-P false 0001539996 XXXXXXXX S000036986 C000113162 C000113163 C000113164 DSS AMERICAFIRST QUANTITATIVE FUNDS 811-22669 0001539996 549300KFIJ1ZWDPJB360 9700 Village Center Drive Suite 50-N Granite Bay 95746 916-787-9940 AmericaFirst Defensive Growth Fund S000036986 549300S3G3X5IG45FY40 2024-06-30 2024-03-28 N 1089080.01 18042.32 1071037.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 N Abbott Laboratories HQD377W2YR662HK5JX27 Abbott Laboratories 002824100 407.00 NS USD 46259.62 4.32 Long EC CORP US N 1 N N N Booking Holdings, Inc. FXM8FAOHMYDIPD38UZ17 Booking Holdings, Inc. 09857L108 13.00 NS USD 47162.44 4.40 Long EC CORP US N 1 N N N Clorox Co. 54930044KVSC06Z79I06 Clorox Co. 189054109 309.00 NS USD 47310.99 4.42 Long EC CORP US N 1 N N N Costco Wholesale Corp. 29DX7H14B9S6O3FD6V18 Costco Wholesale Corp. 22160K105 81.00 NS USD 59343.03 5.54 Long EC CORP US N 1 N N N Eli Lilly & Co. FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co. 532457108 114.00 NS USD 88687.44 8.28 Long EC CORP US N 1 N N N Federated Hermes Institutional Prime Obligations Fund N/A Federated Prime Obligations 60934N203 123087.75 NS USD 123087.75 11.49 Long STIV RF US N 1 N N N International Business Machines Corp. VGRQXHF3J8VDLUA7XE92 International Business Machines Corp. 459200101 275.00 NS USD 52514.00 4.90 Long EC CORP US N 1 N N N Johnson & Johnson 549300G0CFPGEF6X2043 Johnson & Johnson 478160104 283.00 NS USD 44767.77 4.18 Long EC CORP US N 1 N N N McKesson Corp. 549300WZWOM80UCFSF54 McKesson Corp. 58155Q103 99.00 NS USD 53148.15 4.96 Long EC CORP US N 1 N N N Molson Coors Beverage Co. 54930073LBBH6ZCBE225 Molson Coors Beverage Co. Class B 60871R209 654.00 NS USD 43981.50 4.11 Long EC CORP US N 1 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 670100205 440.00 NS USD 56496.00 5.27 Long EC CORP DK N 1 N N N PepsiCo, Inc. FJSUNZKFNQ5YPJ5OT455 PepsiCo, Inc. 713448108 324.00 NS USD 56703.24 5.29 Long EC CORP US N 1 N N N RTX Corp. I07WOS4YJ0N7YRFE7309 RTX Corp. 75513E101 538.00 NS USD 52471.14 4.90 Long EC CORP US N 1 N N N The Southern Co. 549300FC3G3YU2FBZD92 The Southern Co. 842587107 619.00 NS USD 44407.06 4.15 Long EC CORP US N 1 N N N The TJX Companies, Inc. V167QI9I69W364E2DY52 The TJX Companies, Inc. 872540109 442.00 NS USD 44827.64 4.19 Long EC CORP US N 1 N N N Thermo Fisher Scientific, Inc. HCHV7422L5HDJZCRFL38 Thermo Fisher Scientific, Inc. 883556102 84.00 NS USD 48821.64 4.56 Long EC CORP US N 1 N N N Ventas, Inc. ORQTRC074CWLT3DKHT41 Ventas, Inc. 92276F100 987.00 NS USD 42973.98 4.01 Long EC CORP US N 1 N N N Vertex Pharmaceuticals, Inc. 54930015RAQRRZ5ZGJ91 Vertex Pharmaceuticals, Inc. 92532F100 110.00 NS USD 45981.10 4.29 Long EC CORP US N 1 N N N Viatris, Inc 254900ZZTSW7NL773X71 Viatris, Inc 92556V106 1615.00 NS USD 19283.10 1.80 Long EC CORP US N 1 N N N Visa, Inc. 549300JZ4OKEHW3DPJ59 Visa, Inc. 92826C839 170.00 NS USD 47443.60 4.43 Long EC CORP US N 1 N N N 2024-03-28 AmericaFirst Quantitative Funds /s/ Rick Gonsalves Rick Gonsalves Trustee and President XXXX NPORT-EX 2 dssamericafirstdefensive.htm NPORT-EX




Schedule of Investments

March 31, 2024 (unaudited)

AmericaFirst Defensive Growth Fund

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares or Principal

 

 

Security Description

 

 

Amount ($)

 

Fair Value ($)(1)

 

 

 

 

 

 

Common Stocks - 83.99%

 

 

Aerospace & Defense -  4.90%

 

 

 

 

 

RTX Corp.

538

 

52,471

 

 

 

 

 

 

 

 

Beverages -  5.29%

 

 

 

 

 

 

PepsiCo, Inc.

324

 

56,703

 

 

 

 

 

 

 

 

Biotechnology - 4.29%

 

 

 

 

 

 

Vertex Pharmaceuticals, Inc. (2)

 

 

110

 

45,981

 

 

 

 

 

 

 

 

Consumer Staples Distribution -   5.54%

 

 

 

 

 

Costco Wholesale Corp.

 

 

 

81

 

59,343

 

 

 

 

 

 

 

 

Electric Services - 4.15%

 

 

 

 

 

The Southern Co.

 

 

 

619

 

44,407

 

 

 

 

 

 

 

 

Health Care Equipment and Supplies - 4.32%

 

 

 

 

 

Abbott Laboratories

 

 

 

407

 

46,260

 

 

 

 

 

 

 

 

Health Care Providers & Services - 4.96%

 

 

 

 

 

McKesson Corp.

 

 

 

99

 

53,148

 

 

 

 

 

 

 

 

Household Products - 4.42%

 

 

 

 

 

Clorox Co.

 

 

 

 

309

 

47,311

 

 

 

 

 

 

 

 

IT Services - 4.90%

 

 

 

 

 

 

International Business Machines Corp. (2)

 

 

275

 

52,514

 

 

 

 

 

 

 

 

Malt Beverages - 4.11%

 

 

 

 

 

Molson Coors Beverage Co. Class B

 

 

654

 

43,982

 

 

 

 

 

 

 

 

Measuring & Controlling Devices, NEC - 4.56%

 

 

 

 

 

Thermo Fisher Scientific, Inc.

 

 

84

 

48,822

 

 

 

 

 

 

 

 

Pharmaceutical Preparations - 1.80%

 

 

 

 

 

Viatris, Inc

 

 

 

 

1,615

 

19,283

 

 

 

 

 

 

 

 

Pharmaceuticals - 17.74%

 

 

 

 

 

Eli Lilly & Co.

 

 

 

114

 

88,687

Johnson & Johnson

 

 

 

283

 

44,767

Novo Nordisk A/S

 

 

 

440

 

56,496

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

189,950

 

 

 

 

 

 

 

 

Retail-Family Clothing Stores - 4.19%

 

 

 

 

 

The TJX Companies, Inc.

 

 

 

442

 

44,828

 

 

 

 

 

 

 

 

Service-Business Services, NEC - 8.83%

 

 

 

 

 

Booking Holdings, Inc.

 

 

 

13

 

47,162

Visa, Inc.

 

 

 

 

170

 

47,444

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

94,606

 

 

 

 

 

 

 

 

Total Common Stock

 

 

 

(Cost $                  750,411)

 

899,609

 

 

 

 

 

 

 

 

Real Estate Investment Trusts - 4.01%

 

 

 

 

Ventas, Inc.

 

 

 

987

 

42,974

 

 

 

 

 

 

 

 

Total Real Estate Investment Trusts

(Cost $                 42,043)

 

42,974

 

 

 

 

 

 

 

 

Money Market Registered Investment Companies - 11.49%

 

 

 

 

Federated Hermes Institutional Prime Obligations Fund - Institutional Class, 5.37% (4)

123,088

 

123,088

 

 

 

 

Total Money Market Registered Investment Companies

(Cost $               123,088)

 

123,088

 

 

 

 

Total Investments - 99.50%

(Cost $               915,542)

 

1,065,671

 

 

 

 

Other Assets Less Liabilities - .50%

 

 

5,367

 

 

 

 

Total Net Assets - 100.00%

 

 

1,071,038

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)  Statement on Financial Accounting Standard No. 157 "Fair Value Measurements" - Various inputs are used in determining the value of the Fund's investments.

       These inputs are summarized in the three broad levels listed below.

        • Level 1 - quoted prices in active markets for identical securities

        • Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)

        • Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments)

 

       The following is a summary of the inputs used as of March 28, 2024 in valuing the Fund's assets carried at fair value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in

 

Other Financial

Valuation Inputs

 

 

 

Securities

 

Instruments (3)

Level 1 - Quoted Prices

 

 

$

1,065,671

$

-

Level 2 - Other Significant Observable Inputs

 

 

 

 

-

Level 3 - Significant Unobservable Inputs

 

 

-

 

-

Total

 

 

 

$

1,065,671

$

0

 

 

 

 

 

 

 

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term

debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment

Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active

market, such securities are reflected as Level 2.

 

 

 

 

 

 

 

 

(2)   Represents non-income producing securities.

(4)  Investment in affiliate. The yield shown represents the 7-day yield in effect at March 28, 2024.